CHRB Files Medication Complaints Against Hall Of Famers McAnally, Mandella

The California Horse Racing Board has filed medication complaints against trainers Ron McAnally and Richard Mandella, two members of the National Museum of Racing and Hall of Fame who have rarely been cited for violations throughout their careers.

McAnally was notified of a positive test for the Class 1 drug 7-Carboxy-Cannabidiol in Roses and Candy, winner of the third race at Del Mar on Nov. 22, 2020. A split sample confirmed the presence of the substance.

Better known as CBD, Cannabidiol is found in a number of equine products, including tincture oil, pellets, liniment spray and poultices. While it is believed to work as an anti-inflammatory there is limited research on the possible benefits of CBD in horses and its use remains controversial. Because it is not included in the CHRB's classification list of drugs, it becomes a Class 1/Penalty Class A by default, according to CHRB spokesman Mike Marten.  The Association of Racing Commissioners International lists Cannabidiol as a Class 2/Penalty Category B substance.

Marten said a proposed rule change to make Cannabidiol a Class 3/Penalty Category B drug is currently out for public comment and CHRB executive director Scott Chaney and investigators will recommend that stewards treat the alleged infraction as a Class 3 violation. It would still result in the disqualification of the horse, Marten added.

McAnally has not been sanctioned for any medication violations in California since 1998, Marten said. According to www.thoroughbredrulings.com, McAnally received a warning for a positive test for the Class D drug Cimetidine in Kentucky in 2009.

The CHRB filed a complaint against Mandella on May 7 after Jolie Olimpica – third in the Grade 3 San Simeon Stakes on March 13, 2021 – was found in a post-race sample to have 6.1 ng/ml of the Class 4/Penalty Category C drug methocarbamol – a muscle relaxant.  A split sample confirmed the presence of the drug.

Mandella was fined $500 in January 2018 after two anti-inflammatories were found in a post-race sample – his most recent violation. He was also fined $500 for a methocarbamol positive in 2011.

Stewards hearings will be scheduled for both trainers.

The post CHRB Files Medication Complaints Against Hall Of Famers McAnally, Mandella appeared first on Horse Racing News | Paulick Report.

Source of original post

Diodoro Fined $3,500, Horses Disqualified For Drug Positives

Robertino Diodoro, North America's third-leading trainer by wins in 2020, was handed a $3,500 fine and had three horses disqualified from previous races at Oaklawn Park on Monday after they tested positive for Class 4 substances, Thoroughbred Daily News reports.

The punishment entailed four separate rulings, with one each disqualifying the offending horses and the fourth issuing the fine for failing to meet the Arkansas State Racing Commission's “absolute insurer” guidelines for trainers.

Two of the horses tested positive for triamcinolone acetonide, typically used to treat arthritis. Adheretome was taken down from first in a March 19 claiming race at Oaklawn Park after the substance was found in a post-race test, while Weekend Madness was disqualified from fifth after testing positive following a March 1 maiden claimer.

Moment was disqualified from first in an April 3 waver claiming race after testing positive for the relaxant methocarbamol, which can treat exercise-induced muscle soreness.

Diodoro did not immediately indicate to the TDN whether he would appeal the rulings.

Diodoro finished the 2020 Oaklawn Park meet as the track's leading trainer with 52 wins, ahead of Steve Asmussen with 49. If the disqualifications are not appealed successfully, Diodoro's win total would only decrease by one, by virtue of also having the runner-up in Moment's April 3 victory.

Read more at Thoroughbred Daily News.

The post Diodoro Fined $3,500, Horses Disqualified For Drug Positives appeared first on Horse Racing News | Paulick Report.

Source of original post

Verified by MonsterInsights